diabetes

Johnson & Johnson Could Tap The Huge Diabetes Market With New Drug Approval

Johnson & Johnson Could Tap The Huge Diabetes Market With New Drug Approval

Forbes

Takeda Put Actos Sales Ahead of User Safety, Witness Says

Takeda Put Actos Sales Ahead of User Safety, Witness Says

Bloomberg

How Serious Is This News for Diabetes Drugmakers?

How Serious Is This News for Diabetes Drugmakers?

Motley Fool

Merck, Bristol Diabetes Drugs Linked to Pancreatitis Risk

Merck, Bristol Diabetes Drugs Linked to Pancreatitis Risk

Bloomberg

Glaxo Sued By Maryland AG Over Avandia Risks

Glaxo Sued By Maryland AG Over Avandia Risks

Pharmalot

U.S. rejection of Novo drug seen temporary but costly

U.S. rejection of Novo drug seen temporary but costly

Yahoo/Reuters

Takeda Faces First Trial Over Actos Diabetes Drug in L.A.

Takeda Faces First Trial Over Actos Diabetes Drug in L.A.

Bloomberg

Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA

Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA

Yahoo

Takeda Worried About Actos’s Cancer Link, Filing Shows

Takeda Worried About Actos’s Cancer Link, Filing Shows

BusinessWeek

Merck's Dynamic Duo

Merck's Dynamic Duo

Motley Fool